Representative before the EPO

Employment test 51 - 200 employees
Company dna weickmann and weickmann
operating since 1882
Headquarter in Munich and 2 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

We have observed 107 EP applications Wolfgang Weiss has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after December 16, 2012). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP11706256

NATURALLY OCCURRING AUTOANTIBODIES AGAINST ALPHA-SYNUCLEIN THAT INHIBIT THE AGGREGATION AND CYTOTOXICITY OF ALPHA-SYNUCLEIN

IPC classification:
C07K 16/28
Agent:
Wolfgang Weiss, Weickmann & Weickmann PartmbB
Status:
EXAMINATION IN PROGRESS
EP11709731

AZO COMPOUNDS REDUCING FORMATION AND TOXICITY OF AMYLOID BETA AGGREGATION INTERMEDIATES

IPC classification:
A61P 7/06, A61P 25/00, A61P 25/16, A61P 25/28, A61P 43/00, A61K 31/655, A61K 49/10, A61K 51/04
Applicant:
Max-Delbrück-Centrum für Molekulare Medizin (MDC)
Agent:
Wolfgang Weiss, Weickmann & Weickmann PartmbB
Status:
EXAMINATION IN PROGRESS
EP11709733

COMPRESSION TEXTILE COMPRISING CHITOSAN COATED FIBRES

IPC classification:
A61F 13/08
Agent:
Wolfgang Weiss, Weickmann & Weickmann PartmbB
Status:
EXAMINATION IN PROGRESS
EP11777690

COMPOSITIONS FOR LINKING ZINC FINGER MODULES

IPC classification:
C07H 21/04, C12N 5/00, C12P 21/06, A61K 38/04
Agent:
Wolfgang Weiss, Weickmann & Weickmann PartmbB
Status:
GRANT OF PATENT INTENDED
EP11722453

LACTADHERIN-DERIVED PEPTIDES AS ANTIVIRAL AGENTS

IPC classification:
C07K 7/06, C07K 14/47, A23L 1/29, A61K 39/15
Agent:
Wolfgang Weiss, Weickmann & Weickmann PartmbB
Status:
GRANT OF PATENT INTENDED
EP11171910

Graduated compression garments

IPC classification:
A61F 13/08
Agent:
Wolfgang Weiss, Weickmann & Weickmann PartmbB
Status:
APPLICATION REFUSED
EP13157160

Engineered cleavage half-domains

IPC classification:
C07K 14/195, C12N 9/22
Applicant:
Sangamo BioSciences, Inc.
Agent:
Wolfgang Weiss, Weickmann & Weickmann PartmbB
Status:
GRANT OF PATENT INTENDED
EP11740153

ENGINEERED CLEAVAGE HALF-DOMAINS

IPC classification:
C07K 14/195, C12N 9/22
Applicant:
Sangamo BioSciences, Inc.
Agent:
Wolfgang Weiss, Weickmann & Weickmann PartmbB
Status:
EXAMINATION IN PROGRESS
EP11755362

RECOMBINANT MYCOBACTERIUM AS VACCINE FOR USE IN HUMANS

IPC classification:
A61K 39/04
Agent:
Wolfgang Weiss, Weickmann & Weickmann PartmbB
Status:
GRANT OF PATENT INTENDED
EP11826479

PROCESS FOR CONCENTRATING OMEGA-3 FATTY ACIDS

IPC classification:
C07C 51/42, C07C 57/03, C11C 1/08
Agent:
Wolfgang Weiss, Weickmann & Weickmann PartmbB
Status:
GRANT OF PATENT INTENDED
EP11768285

COMPOUND FOR TREATMENT OF RESPIRATORY CONDITION OR DISEASE

IPC classification:
A61P 11/06, A61P 31/16, A61K 31/501, A61K 45/06
Applicant:
Biota Scientific Management Pty Ltd
Agent:
Wolfgang Weiss, Weickmann & Weickmann PartmbB
Status:
The patent has been granted
EP13166487

Targeted genomic modification with partially single-stranded donor molecules

IPC classification:
C07H 21/00, C07K 19/00, C12N 9/22, C12N 15/62, C12N 15/90
Agent:
Wolfgang Weiss, Weickmann & Weickmann PartmbB
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP11783865

NOVEL DNA-BINDING PROTEINS AND USES THEREOF

IPC classification:
C12N 9/22, C12N 15/62, A61K 38/00, A61K 38/16
Applicant:
Sangamo BioSciences, Inc.
Agent:
Wolfgang Weiss, Weickmann & Weickmann PartmbB
Status:
The patent has been granted
EP11797405

COMPOUND FOR THE TREATMENT OF ENTEROVIRUSES

IPC classification:
A61P 31/14, A61K 31/501, A61K 31/506
Applicant:
Biota Scientific Management Pty Ltd
Agent:
Wolfgang Weiss, Weickmann & Weickmann PartmbB
Status:
The patent has been granted
EP12708774

(1,2,4)TRIAZOLO[4,3-A]QUINOXALINE DERIVATIVES AS INHIBITORS OF PHOSPHODIESTERASES

IPC classification:
A61P 25/00, C07D 487/04, A61K 31/519
Applicant:
Boehringer Ingelheim International GmbH
Agent:
Wolfgang Weiss, Weickmann & Weickmann PartmbB
Status:
PATENT GRANTED
EP12703494

PREVENTION OF HYPOGLYCAEMIA IN DIABETES MELLITUS TYPE 2 PATIENTS

IPC classification:
A61P 3/10, A61P 5/50, A61K 31/155, A61K 38/22
Applicant:
Sanofi-Aventis Deutschland GmbH
Agent:
Wolfgang Weiss, Weickmann & Weickmann PartmbB
Status:
EXAMINATION IN PROGRESS
EP12712106

PREVENTION OF HYPOGLYCAEMIA IN DIABETES MELLITUS TYPE 2 PATIENTS

IPC classification:
A61P 3/08, A61K 31/64, A61K 38/26
Applicant:
Sanofi-Aventis Deutschland GmbH
Agent:
Wolfgang Weiss, Weickmann & Weickmann PartmbB
Status:
PATENT GRANTED
EP12710734

IMPROVED DIFFUSION LAYER FOR AN ENZYMATIC IN-VIVO SENSOR

IPC classification:
C12Q 1/00
Applicant:
F. Hoffmann-La Roche AG
Applicant:
Roche Diagnostics GmbH
Agent:
Wolfgang Weiss, Weickmann & Weickmann PartmbB
Status:
PATENT GRANTED
EP12710278

GRADUATED COMPRESSION GARMENTS

IPC classification:
A61F 13/08
Agent:
Wolfgang Weiss, Weickmann & Weickmann PartmbB
Status:
PATENT GRANTED
EP12182023

Inflatable bone tamp

IPC classification:
A61B 17/88
Agent:
Wolfgang Weiss, Weickmann & Weickmann PartmbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11799953

MODIFICATION OF PROPYLENE POLYMERS

IPC classification:
B29C 47/00, C08F 8/06, C08F 8/50, C08F 10/06, C08J 5/18, C08K 3/20, C08K 5/00, C08K 5/09, C08L 23/10, C08L 23/26, D01F 6/06
Applicant:
Polymers CRC Ltd.
Agent:
Wolfgang Weiss, Weickmann & Weickmann PartmbB
Status:
EXAMINATION IN PROGRESS
EP12723132

LIXISENATIDE AND METFORMIN FOR TREATMENT OF DIABETES TYPE 2

IPC classification:
A61P 3/10, A61K 31/155, A61K 38/26
Applicant:
Sanofi-Aventis Deutschland GmbH
Agent:
Wolfgang Weiss, Weickmann & Weickmann PartmbB
Status:
PATENT GRANTED
EP12722324

PHARMACEUTICAL COMBINATION FOR USE IN INDUCING WEIGHT LOSS IN DIABETES TYPE 2 PATIENTS OR/AND FOR PREVENTING WEIGHT GAIN IN DIABETES TYPE 2 PATIENTS

IPC classification:
A61P 3/04, A61P 3/10, A61K 31/155, A61K 38/26
Applicant:
Sanofi-Aventis Deutschland GmbH
Agent:
Wolfgang Weiss, Weickmann & Weickmann PartmbB
Status:
GRANT OF PATENT INTENDED
EP12721268

LIXISENATIDE AS ADD-ON THERAPY TO BASAL INSULIN IN TYPE 2 DIABETES

IPC classification:
A61P 3/04, A61P 3/10, A61K 31/155, A61K 38/26, A61K 38/28
Applicant:
Sanofi-Aventis Deutschland GmbH
Agent:
Wolfgang Weiss, Weickmann & Weickmann PartmbB
Status:
PATENT GRANTED
EP12720503

WHOLE CELL BIOCATALYST COMPRISING A PRENYLTRANSFERASE

IPC classification:
C07K 19/00, C12N 11/16, C12P 5/00
Agent:
Wolfgang Weiss, Weickmann & Weickmann PartmbB
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11819230

BLOCK SYNTHESIS OF OLIGORIBONUCLEOTIDES

IPC classification:
C07H 21/00, C07H 21/02, C07H 23/00
Applicant:
McGill University - The Royal Institution for the Advancement of Learning
Agent:
Wolfgang Weiss, Weickmann & Weickmann PartmbB
Status:
EXAMINATION IN PROGRESS
EP12720196

PHARMACEUTICAL COMBINATION FOR USE IN THE TREATMENT OF DIABETES TYPE 2

IPC classification:
A61P 3/10, A61K 31/155, A61K 38/22
Applicant:
Sanofi-Aventis Deutschland GmbH
Agent:
Wolfgang Weiss, Weickmann & Weickmann PartmbB
Status:
EXAMINATION IN PROGRESS
EP11831256

METHODS AND COMPOSITIONS FOR INHIBITING VIRAL ENTRY INTO CELLS

IPC classification:
C07K 14/16, C12P 21/00, A61K 38/16, A61K 48/00
Applicant:
Sangamo BioSciences, Inc.
Agent:
Wolfgang Weiss, Weickmann & Weickmann PartmbB
Status:
GRANT OF PATENT INTENDED
EP12726137

ANTIINFECTIVE COMPOSITION

IPC classification:
A61P 31/12, A61P 31/22, A61P 35/00, A61K 31/726, A61K 31/727
Agent:
Wolfgang Weiss, Weickmann & Weickmann PartmbB
Status:
GRANT OF PATENT INTENDED
EP12189463

Method and device for detecting illegal drugs

IPC classification:
G01N 33/52, G01N 33/543, G01N 33/94
Applicant:
Securetec Detektions-Systeme AG
Agent:
Wolfgang Weiss, Weickmann & Weickmann PartmbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12197563

Improved transfer medium

IPC classification:
B41M 5/025, B41M 5/035, B41M 5/50, D06P 5/00, D06P 5/28
Agent:
Wolfgang Weiss, Weickmann & Weickmann PartmbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12734726

METHODS AND DRUG PRODUCTS FOR TREATING ALZHEIMER'S DISEASE

IPC classification:
C07D 417/12, C12Q 1/68, A61K 31/4436, A61K 31/4439
Applicant:
Takeda Pharmaceutical Company Limited
Agent:
Wolfgang Weiss, Weickmann & Weickmann PartmbB
Status:
EXAMINATION IN PROGRESS
EP13160375

Pharmaceutical microemulsion for preventing supramolecular aggregation of amphiphilic molecules

IPC classification:
A61K 9/107, A61K 47/10, A61K 47/14, A61K 47/26, A61K 47/44
Agent:
Wolfgang Weiss, Weickmann & Weickmann PartmbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12756417

PHARMACEUTICAL COMBINATION FOR USE IN GLYCEMIC CONTROL IN DIABETES TYPE 2 PATIENTS

IPC classification:
A61K 31/155, A61K 31/4439, A61K 38/26
Applicant:
Sanofi-Aventis Deutschland GmbH
Agent:
Wolfgang Weiss, Weickmann & Weickmann PartmbB
Status:
PATENT GRANTED
EP12755853

PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT OF A NEURODEGENERATIVE DISEASE

IPC classification:
A61P 25/28, A61K 38/26
Applicant:
University of Ulster
Applicant:
Sanofi-Aventis Deutschland GmbH
Agent:
Wolfgang Weiss, Weickmann & Weickmann PartmbB
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11779721

NUCLEIC ACIDSBUILDING BLOCKS AND METHODS FOR THE SYNTHESIS OF 5-HYDROXYMETHYLCYTOSINE-CONTAINING

IPC classification:
C07D 498/04
Applicant:
Ludwig-Maximilians-Universität München
Agent:
Wolfgang Weiss, Weickmann & Weickmann PartmbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12758827

THE MIRNA-212/132 FAMILY AS A THERAPEUTIC TARGET

IPC classification:
C12N 15/113, A61K 31/7088, A61K 31/713
Applicant:
Medizinische Hochschule Hannover
Applicant:
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V.
Agent:
Wolfgang Weiss, Weickmann & Weickmann PartmbB
Status:
GRANT OF PATENT INTENDED
EP12762304

AZO MEDIATORS

IPC classification:
C07C 281/20, C07D 295/215, C12Q 1/26, C12Q 1/32
Applicant:
F. Hoffmann-La Roche AG
Applicant:
Roche Diagnostics GmbH
Applicant:
Roche Diabetes Care GmbH
Agent:
Wolfgang Weiss, Weickmann & Weickmann PartmbB
Status:
PATENT GRANTED
EP12766981

GLP-1 AGONIST FOR USE IN THE TREATMENT OF STENOSIS OR/AND OBSTRUCTION IN THE BILIARY TRACT

IPC classification:
A61K 38/26
Applicant:
Sanofi-Aventis Deutschland GmbH
Agent:
Wolfgang Weiss, Weickmann & Weickmann PartmbB
Status:
GRANT OF PATENT INTENDED
EP12766695

GLP-1 AGONIST FOR USE IN THE TREATMENT OF STENOSIS OR/AND OBSTRUCTION IN THE PANCREATIC DUCT SYSTEM

IPC classification:
A61P 1/18, A61P 35/00, A61K 38/26
Applicant:
Sanofi-Aventis Deutschland GmbH
Agent:
Wolfgang Weiss, Weickmann & Weickmann PartmbB
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13154462

Method of producing carbon-enriched biomass material

IPC classification:
C10L 5/44, C10L 9/06, C10L 9/08
Agent:
Wolfgang Weiss, Weickmann & Weickmann PartmbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12839452

TREATMENT AGENT AND/OR PROPHYLACTIC AGENT FOR SIDE EFFECTS OF CANCER DRUGS

IPC classification:
A61P 7/06, A61P 43/00, A61K 31/197, A61K 31/28, A61K 33/06, A61K 33/26, A61K 33/30
Applicant:
Kochi University
Applicant:
SBI Pharmaceuticals Co Ltd
Agent:
Wolfgang Weiss, Weickmann & Weickmann PartmbB
Status:
GRANT OF PATENT INTENDED
EP12840143

ANEMIA OF CANCER IMPROVING / PROPHYLACTIC AGENT

IPC classification:
A61P 7/06, A61P 43/00, A61K 31/197, A61K 31/28, A61K 33/06, A61K 33/24, A61K 33/26, A61K 33/30, A61K 33/34
Applicant:
SBI Pharmaceuticals Co Ltd
Agent:
Wolfgang Weiss, Weickmann & Weickmann PartmbB
Status:
EXAMINATION IN PROGRESS
EP12775720

TREATMENT PROTOCOL OF DIABETES TYPE 2

IPC classification:
A61P 3/04, A61P 3/10, A61K 31/155, A61K 38/26, A61K 38/28
Applicant:
Sanofi-Aventis Deutschland GmbH
Agent:
Wolfgang Weiss, Weickmann & Weickmann PartmbB
Status:
GRANT OF PATENT INTENDED
EP12843033

PLASTID-EXPRESSED MYCOBACTERIUM TUBERCULOSIS VACCINE ANTIGENS ESAT-6 AND MTB72F FUSED TO CHOLERA TOXIN B SUBUNIT

IPC classification:
C12N 5/10, C12N 15/82, A01H 5/00, A61K 39/04
Applicant:
University of Central Florida Research Foundation Inc
Agent:
Wolfgang Weiss, Weickmann & Weickmann PartmbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12844486

ORALLY-ADMINISTERED PLASTID EXPRESSED CHOLERA TOXIN B SUBUNIT-EXENDIN 4 AS TREATMENT FOR TYPE 2 DIABETES

IPC classification:
A61P 3/00, A61P 3/04, A61K 31/40, A61K 36/28
Applicant:
University of Central Florida Research Foundation Inc
Agent:
Wolfgang Weiss, Weickmann & Weickmann PartmbB
Status:
PATENT GRANTED
EP14166877

Long-acting formulations of insulins

IPC classification:
A61K 9/00, A61K 9/08, A61K 31/00, A61K 38/00, A61K 38/26, A61K 38/28
Applicant:
Sanofi, S.A.
Agent:
Wolfgang Weiss, Weickmann & Weickmann PartmbB
Status:
EXAMINATION IN PROGRESS
EP14164371

miRNA fingerprint from patient's blood samples in the diagnosis of Wilms' tumour

IPC classification:
C12Q 1/68
Applicant:
Comprehensive Biomarker Center GmbH
Agent:
Wolfgang Weiss, Weickmann & Weickmann PartmbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12158247

Method and device for detecting analytes

IPC classification:
G01N 33/558
Applicant:
Securetec Detektions-Systeme AG
Agent:
Wolfgang Weiss, Weickmann & Weickmann PartmbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14172390

Controlled release pharmaceutical compositions comprising a fumaric acid ester

IPC classification:
A61K 9/20
Applicant:
Forward Pharma A/S
Agent:
Wolfgang Weiss, Weickmann & Weickmann PartmbB
Agent:
Henkel Breuer & Partner
Agent:
HGF Limited
Status:
PATENT GRANTED
EP14172398

Controlled release pharmaceutical compositions comprising a fumaric acid ester

IPC classification:
A61K 9/20, A61K 9/50
Applicant:
Forward Pharma A/S
Agent:
Wolfgang Weiss, Weickmann & Weickmann PartmbB
Agent:
Henkel Breuer & Partner
Status:
PATENT GRANTED
EP12159737

Process for preparing sterile Brinzolamide

IPC classification:
A61K 31/542
Agent:
Wolfgang Weiss, Weickmann & Weickmann PartmbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13700735

SURGICAL BONE HOLDING FORCEPS WITH A DRILLING GUIDE

IPC classification:
A61B 17/17
Applicant:
Kyon AG
Agent:
Wolfgang Weiss, Weickmann & Weickmann PartmbB
Status:
PATENT GRANTED
EP14165474

Anti-Alzheimer's disease treatment of subjects identified by detecting the presence of a genetic variant in the TOMM40 gene at rs10524523

IPC classification:
C12Q 1/68
Agent:
Wolfgang Weiss, Weickmann & Weickmann PartmbB
Status:
EXAMINATION IN PROGRESS
EP13703961

METHODS AND COMPOSITIONS FOR MODULATING ANGIOGENESIS AND VASCULOGENESIS

IPC classification:
C12N 5/071, A61K 35/28
Agent:
Wolfgang Weiss, Weickmann & Weickmann PartmbB
Status:
GRANT OF PATENT INTENDED
EP12749896

METHOD OF PREPARING REGENERATED HAIR FOLLICLE GERM FOR TRANSPLANTATION IN WHICH HAIR COLOR IS CONTROLLED, COMPOSITION INCLUDING REGENERATED HAIR FOLLICLE GERM FOR TRANSPLANTATION, AND METHOD OF TRANSPLANTING REGENERATED HAIR FOLLICLE GERM

IPC classification:
C12N 5/071, C12N 5/10, A61L 27/00, A61L 27/38
Applicant:
Organ Technologies Inc.
Agent:
Wolfgang Weiss, Weickmann & Weickmann PartmbB
Status:
GRANT OF PATENT INTENDED
EP12182994

Inhibitors of alpha6 integrin/E-cadherin complex

IPC classification:
A61P 35/04, C12N 15/00, G01N 33/00, A61K 38/17
Applicant:
University of Torino (Università degli Studi di Torino)
Agent:
Wolfgang Weiss, Weickmann & Weickmann PartmbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14176605

RNA interference mediating small RNA molecules

IPC classification:
C12N 15/10, C12Q 1/68
Applicant:
Europäisches Laboratorium für Molekularbiologie (European Molecular Biology Laboratory (EMBL), Heidelberg)
Applicant:
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V.
Agent:
Wolfgang Weiss, Weickmann & Weickmann PartmbB
Status:
PATENT GRANTED
EP12782172

FLUID INJECTION SYSTEM HAVING VARIOUS SYSTEMS FOR CONTROLLING AN INJECTION PROCEDURE

IPC classification:
A61M 5/00, A61M 5/145, A61M 5/168, A61M 5/36
Applicant:
Bayer Healthcare LLC
Applicant:
Bayer Medical Care Inc.
Agent:
Wolfgang Weiss, Weickmann & Weickmann PartmbB
Status:
EXAMINATION IN PROGRESS
EP13709177

CYCLIC SINGLE MOLECULE SEQUENCING PROCESS

IPC classification:
C12Q 1/68
Agent:
Wolfgang Weiss, Weickmann & Weickmann PartmbB
Status:
EXAMINATION IN PROGRESS
EP13707408

METHOD AND DEVICE FOR DETECTING ANALYTES

IPC classification:
G01N 33/558
Applicant:
Securetec Detektions-Systeme AG
Agent:
Wolfgang Weiss, Weickmann & Weickmann PartmbB
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13743314

DENTAL IMPLANT AND METHOD FOR PRODUCING SAME

IPC classification:
A61C 8/00, A61L 27/00
Applicant:
Organ Technologies Inc.
Agent:
Wolfgang Weiss, Weickmann & Weickmann PartmbB
Status:
GRANT OF PATENT INTENDED
EP14150248

Antimicrobial Locking Solutions Comprising Taurinamide Derivatives and Biologically Acceptable Salts and Acids, with the addition of Small Concentrations of Heparin

IPC classification:
A61K 31/382, A61K 31/727
Agent:
Wolfgang Weiss, Weickmann & Weickmann PartmbB
Agent:
Multiple attorneys, Murgitroyd & Company
Status:
EXAMINATION IN PROGRESS
EP13712795

IMPROVED SPACER MEMBRANE FOR AN ENZYMATIC IN-VIVO SENSOR

IPC classification:
C12Q 1/00
Applicant:
F. Hoffmann-La Roche AG
Applicant:
Roche Diagnostics GmbH
Applicant:
Roche Diabetes Care GmbH
Agent:
Wolfgang Weiss, Weickmann & Weickmann PartmbB
Status:
GRANT OF PATENT INTENDED
EP13156363

Highly efficient production of blood glucose test strips

IPC classification:
C12Q 1/54, G01N 33/535
Applicant:
F. Hoffmann-La Roche AG
Applicant:
Roche Diagnostics GmbH
Agent:
Wolfgang Weiss, Weickmann & Weickmann PartmbB
Status:
APPLICATION REFUSED
EP13719509

QUANTIFICATION OF IMPURITIES FOR RELEASE TESTING OF PEPTIDE PRODUCTS

IPC classification:
G01N 33/68
Applicant:
Sanofi-Aventis Deutschland GmbH
Agent:
Wolfgang Weiss, Weickmann & Weickmann PartmbB
Status:
GRANT OF PATENT INTENDED
EP14194715

Derivatives of UK-2A

IPC classification:
C07D 405/12
Applicant:
Dow AgroSciences LLC
Agent:
Wolfgang Weiss, Weickmann & Weickmann PartmbB
Status:
PATENT GRANTED
EP13184458

Caspase-1 imaging probes

IPC classification:
C07D 487/00, C12Q 1/37, G01N 33/542
Applicant:
Sanofi-Aventis Deutschland GmbH
Applicant:
Europäisches Laboratorium für Molekularbiologie (European Molecular Biology Laboratory (EMBL), Heidelberg)
Applicant:
Institut "Jožef Stefan"
Agent:
Wolfgang Weiss, Weickmann & Weickmann PartmbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13797604

HETEROCYCLIC COMPOUND

IPC classification:
A61P 1/04, A61P 17/06, A61P 19/02, A61P 25/00, A61P 29/00, A61P 37/00, A61P 43/00, C07D 471/04, A61K 31/437, A61K 31/444, A61K 31/5377
Applicant:
Takeda Pharmaceutical Company Limited
Agent:
Wolfgang Weiss, Weickmann & Weickmann PartmbB
Status:
EXAMINATION IN PROGRESS
EP11174348

Combination therapy with iron-based phosphate absorbers

IPC classification:
A61P 13/12, A61K 33/36
Applicant:
SeBo GmbH
Agent:
Wolfgang Weiss, Weickmann & Weickmann PartmbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13759481

INHIBITORS OF ALPHA6 INTEGRIN/E-CADHERIN COMPLEX AND THEIR THERAPEUTIC AND DIAGNOSTIC USE IN CANCER

IPC classification:
A61P 35/04, C12N 15/00, G01N 33/00, A61K 38/17
Applicant:
University of Torino (Università degli Studi di Torino)
Agent:
Wolfgang Weiss, Weickmann & Weickmann PartmbB
Status:
EXAMINATION IN PROGRESS
EP13773767

EXENDIN-4 DERIVATIVES AS DUAL GLP1/GLUCAGON AGONISTS

IPC classification:
C07K 14/575, C07K 14/605, A61K 38/26
Applicant:
Sanofi, S.A.
Agent:
Wolfgang Weiss, Weickmann & Weickmann PartmbB
Status:
The patent has been granted
EP13789517

REMOVAL OF UNDESIRED COMPONENTS FROM OIL COMPOSITIONS

IPC classification:
C11B 3/00, C11B 3/06, C11B 3/12, A23D 9/00, A23D 9/02
Agent:
Wolfgang Weiss, Weickmann & Weickmann PartmbB
Status:
EXAMINATION IN PROGRESS
EP13814436

LACTOBACILLUS SANFRANCISCENSIS MICROORGANISMS FROM SOURDOUGH

IPC classification:
C12R 1/225, A61K 35/74
Agent:
Wolfgang Weiss, Weickmann & Weickmann PartmbB
Status:
PATENT GRANTED
EP13814892

EXENDIN-4 DERIVATIVES

IPC classification:
C07K 14/605, A61K 38/26
Applicant:
Sanofi, S.A.
Agent:
Wolfgang Weiss, Weickmann & Weickmann PartmbB
Status:
EXAMINATION IN PROGRESS
EP13810958

FUNCTIONALIZED EXENDIN-4 DERIVATIVES

IPC classification:
C07K 14/605, A61K 38/26
Applicant:
Sanofi, S.A.
Agent:
Wolfgang Weiss, Weickmann & Weickmann PartmbB
Status:
EXAMINATION IN PROGRESS
EP13810957

EXENDIN-4 DERIVATIVES AS DUAL GLP1/GIP OR TRIGONAL GLP1/GIP/GLUCAGON AGONISTS

IPC classification:
C07K 14/605, A61K 38/26
Applicant:
Sanofi, S.A.
Agent:
Wolfgang Weiss, Weickmann & Weickmann PartmbB
Status:
The patent has been granted
EP13811510

DUAL GLP1/GIP OR TRIGONAL GLP1/GIP/GLUCAGON AGONISTS

IPC classification:
C07K 14/605, A61K 38/26
Applicant:
Sanofi, S.A.
Agent:
Wolfgang Weiss, Weickmann & Weickmann PartmbB
Status:
EXAMINATION IN PROGRESS
EP14702838

USE OF MICROORGANISMS FOR THE PREVENTION AND TREATMENT OF INTESTINAL DISEASES

IPC classification:
A23L 1/30, A61K 35/74
Agent:
Wolfgang Weiss, Weickmann & Weickmann PartmbB
Status:
EXAMINATION IN PROGRESS
EP14705543

HIGHLY EFFICIENT PRODUCTION OF BLOOD GLUCOSE TEST STRIPS

IPC classification:
C12Q 1/54, G01N 33/535
Applicant:
F. Hoffmann-La Roche AG
Applicant:
Roche Diagnostics GmbH
Applicant:
Roche Diabetes Care GmbH
Agent:
Wolfgang Weiss, Weickmann & Weickmann PartmbB
Status:
EXAMINATION REQUESTED
EP11703166

EXTRACELLULAR IFI16 AS THERAPEUTIC AGENTS

IPC classification:
A61P 31/00, A61P 37/00, C07K 16/24, A61K 39/395
Applicant:
University of Eastern Piedmont (Università degli Studi del Piemonte Orientale “Amedeo Avogadro)
Agent:
Wolfgang Weiss, Weickmann & Weickmann PartmbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP15166243

CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER

IPC classification:
A61K 9/20
Applicant:
Forward Pharma A/S
Agent:
Wolfgang Weiss, Weickmann & Weickmann PartmbB
Agent:
Henkel Breuer & Partner
Agent:
HGF Limited
Status:
EXAMINATION IN PROGRESS
EP14708065

IMPROVED SURFACE DISPLAY OF FUNCTIONAL PROTEINS IN A BROAD RANGE OF GRAM NEGATIVE BACTERIA

IPC classification:
C12N 15/10, C12N 15/62
Agent:
Wolfgang Weiss, Weickmann & Weickmann PartmbB
Status:
EXAMINATION IN PROGRESS
EP14710915

SYNTHESIS OF HYDANTOIN CONTAINING PEPTIDE PRODUCTS

IPC classification:
C07D 233/72, C07K 5/00, C07K 14/00
Applicant:
Sanofi-Aventis Deutschland GmbH
Agent:
Wolfgang Weiss, Weickmann & Weickmann PartmbB
Status:
PATENT GRANTED
EP14710918

SYNTHESIS OF CYCLIC IMIDE CONTAINING PEPTIDE PRODUCTS

IPC classification:
C07D 207/00, C07K 14/00
Applicant:
Sanofi-Aventis Deutschland GmbH
Agent:
Wolfgang Weiss, Weickmann & Weickmann PartmbB
Status:
PATENT GRANTED
EP14711738

METHOD AND REAGENT FOR DETERMINING VITAMIN D METABOLITES

IPC classification:
G01N 33/82
Agent:
Wolfgang Weiss, Weickmann & Weickmann PartmbB
Status:
The patent has been granted
EP11805020

DETERMINATION OF THE EFFICACY OF A LIVE RECOMBINANT ANTI-MYCOBACTERIAL VACCINATION

IPC classification:
G01N 33/50, G01N 33/68, A61K 39/04, A61K 39/05
Applicant:
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V.
Agent:
Wolfgang Weiss, Weickmann & Weickmann PartmbB
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11723919

Pharmaceutical Composition Comprising AVE0010 and Insulin Glargine

IPC classification:
A61P 3/10, A61P 5/50, A61K 38/26, A61K 38/28
Applicant:
Sanofi-Aventis Deutschland GmbH
Agent:
Wolfgang Weiss, Weickmann & Weickmann PartmbB
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11777679

GENOME EDITING OF A ROSA LOCUS USING ZINC-FINGER NUCLEASES

IPC classification:
C12N 9/22, C12N 15/10, C12N 15/90, A01K 67/027, A61K 38/00
Applicant:
Sangamo BioSciences, Inc.
Agent:
Wolfgang Weiss, Weickmann & Weickmann PartmbB
Status:
PATENT GRANTED
EP14729687

INSULIN GLARGINE/LIXISENATIDE FIXED RATIO FORMULATION

IPC classification:
A61P 3/10, A61K 38/26, A61K 38/28
Applicant:
Sanofi-Aventis Deutschland GmbH
Agent:
Wolfgang Weiss, Weickmann & Weickmann PartmbB
Status:
EXAMINATION IN PROGRESS
EP14818704

SPHEROIDAL GRAPHITE CAST IRON

IPC classification:
B22D 27/20, C21C 1/10, C22C 37/04
Applicant:
Kabushiki Kaisha Riken
Agent:
Wolfgang Weiss, Weickmann & Weickmann PartmbB
Status:
GRANT OF PATENT INTENDED
EP14748179

25-OH VITAMIN D DERIVATIVES FOR DETERMINATION OF VITAMIN D METABOLITES

IPC classification:
C07C 401/00, A61K 31/593
Agent:
Wolfgang Weiss, Weickmann & Weickmann PartmbB
Status:
The patent has been granted
EP16150673

METHODS AND COMPOSITIONS FOR MODULATING PD1

IPC classification:
A61P 31/12, A61P 35/00, C07H 21/00, C07K 14/435, C12N 5/0783, C12N 9/22, A61K 31/7088, A61K 35/17, A61K 38/17
Applicant:
Sangamo BioSciences, Inc.
Agent:
Wolfgang Weiss, Weickmann & Weickmann PartmbB
Status:
EXAMINATION REQUESTED
EP11192820

Microorganism having enhanced L-valine productivity and method for producing L-valine using the same

IPC classification:
C12N 1/20, C12P 13/08, C12R 1/15
Applicant:
Cj Cheiljedang Corporation
Agent:
Wolfgang Weiss, Weickmann & Weickmann PartmbB
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11782141

PATELLAR LIGAMENT SPACER FOR ACL INJURIES

IPC classification:
A61B 17/56, A61F 2/38
Applicant:
Kyon AG
Agent:
Wolfgang Weiss, Weickmann & Weickmann PartmbB
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12197026

Preparation of tetrahydropyrido[4,3-b]indole derivatives

IPC classification:
C07D 471/04, A61K 9/16, A61K 9/20, A61K 31/44
Applicant:
Institute of Pharmacology and Toxicology - Academy of Military Medical Sciences P.L.A. China
Agent:
Wolfgang Weiss, Weickmann & Weickmann PartmbB
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11858349

METHOD FOR PRODUCING REGENERATIVE ORGAN PRIMORDIUM PROVIDED WITH GUIDE FOR TRANSPLANTATION, COMPOSITION CONTAINING REGENERATIVE ORGAN PRIMORDIUM PROVIDED WITH GUIDE FOR TRANSPLANTATION PRODUCED THEREBY, AND METHOD FOR TRANSPLANTING REGENERATIVE ORGAN PRIMORDIUM PROVIDED WITH GUIDE FOR TRANSPLANTATION

IPC classification:
C12N 5/077, A61L 27/00
Applicant:
Organ Technologies Inc.
Agent:
Wolfgang Weiss, Weickmann & Weickmann PartmbB
Status:
EXAMINATION IN PROGRESS
EP11758244

SURFACE DISPLAY OF POLYPEPTIDES CONTAINING A METAL PORPHYRIN OR A FLAVIN

IPC classification:
C12N 9/02, C12N 15/10, C12N 15/62, C12P 21/02
Agent:
Wolfgang Weiss, Weickmann & Weickmann PartmbB
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11833365

Methods and compositions for treating hemophilia B

IPC classification:
C07K 14/47, C12N 9/64, A61K 31/7088, A61K 45/06, A61K 48/00
Applicant:
Sangamo BioSciences, Inc.
Agent:
Wolfgang Weiss, Weickmann & Weickmann PartmbB
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP10747854

USE OF AVE0010 FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF DIABETES MELLITUS TYPE 2

IPC classification:
A61P 3/10, A61K 38/22, A61K 38/26
Applicant:
Sanofi-Aventis Deutschland GmbH
Agent:
Wolfgang Weiss, Weickmann & Weickmann PartmbB
Status:
PATENT GRANTED
EP11740767

DRUG COMBINATIONS WITH FLUORO-SUBSTITUTED OMEGA-CARBOXYARYL DIPHENYL UREA FOR THE TREATMENT AND PREVENTION OF DISEASES AND CONDITIONS

IPC classification:
A61P 35/00, A61K 31/44, A61K 31/505, A61K 31/519
Applicant:
Bayer Healthcare LLC
Agent:
Wolfgang Weiss, Weickmann & Weickmann PartmbB
Status:
APPLICATION REFUSED
EP11811539

RECOMBINANT MYCOBACTERIUM AS A VACCINE

IPC classification:
C07K 14/35, C12N 15/74, G01N 33/50, A61K 38/00, A61K 39/00, A61K 39/02, A61K 39/04
Applicant:
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V.
Agent:
Wolfgang Weiss, Weickmann & Weickmann PartmbB
Status:
PATENT GRANTED
EP11719501

Microfluidic system with sample pre-treatment

IPC classification:
B01L 3/00, G01N 33/558, G01N 33/94
Applicant:
Securetec Detektions-Systeme AG
Agent:
Wolfgang Weiss, Weickmann & Weickmann PartmbB
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11703429

PROCESS FOR THE PREPARATION OF PROPIONIC ACID DERIVATIVES

IPC classification:
C07D 413/12
Applicant:
F. Hoffmann-La Roche AG
Agent:
Wolfgang Weiss, Weickmann & Weickmann PartmbB
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP15166206

RECOMBINANT MYCOBACTERIUM AS AN IMMUNOTHERAPEUTIC AGENT FOR THE TREATMENT OF CANCER

IPC classification:
A61K 39/00, A61K 39/04
Agent:
Wolfgang Weiss, Weickmann & Weickmann PartmbB
Status:
APPLICATION PUBLISHED
EP15174524

SINGLE MOLECULE ANALYSIS IN AN ELECTRICAL FIELD

IPC classification:
C12Q 1/68, G01N 1/40
Agent:
Wolfgang Weiss, Weickmann & Weickmann PartmbB
Status:
APPLICATION REFUSED
EP11742576

TARGETED GENOMIC MODIFICATION WITH PARTIALLY SINGLE-STRANDED DONOR MOLECULES

IPC classification:
C07H 21/00, C12N 9/22, C12N 15/87, C12N 15/90
Applicant:
Sangamo BioSciences, Inc.
Agent:
Wolfgang Weiss, Weickmann & Weickmann PartmbB
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT

Please Sign in to use this feature